HY-100036-10mg
|
MedChemexpress LLC
|
MK-4101 [CAS 935273-79-3]
|
|
Cancer-programmed cell death
|
|
HY-100036-100mg
|
MedChemexpress LLC
|
MK-4101 [CAS 935273-79-3]
|
|
Cancer-programmed cell death
|
|
HY-100036-2mg
|
MedChemexpress LLC
|
MK-4101 [CAS 935273-79-3]
|
|
Cancer-programmed cell death
|
|
HY-100036-25mg
|
MedChemexpress LLC
|
MK-4101 [CAS 935273-79-3]
|
|
Cancer-programmed cell death
|
|
HY-100036-5mg
|
MedChemexpress LLC
|
MK-4101 [CAS 935273-79-3]
|
|
Cancer-programmed cell death
|
|
HY-100036-50mg
|
MedChemexpress LLC
|
MK-4101 [CAS 935273-79-3]
|
|
Cancer-programmed cell death
|
|
HY-100208-10mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-100mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-25mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-5mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100208-50mg
|
MedChemexpress LLC
|
HC-067047 [CAS 883031-03-6]
|
|
Cancer-programmed cell death
|
|
HY-100249-10mg
|
MedChemexpress LLC
|
XEN723 [CAS 1072803-08-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100249-100mg
|
MedChemexpress LLC
|
XEN723 [CAS 1072803-08-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100249-25mg
|
MedChemexpress LLC
|
XEN723 [CAS 1072803-08-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100249-5mg
|
MedChemexpress LLC
|
XEN723 [CAS 1072803-08-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100249-50mg
|
MedChemexpress LLC
|
XEN723 [CAS 1072803-08-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-100483-1mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-10mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-100mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-25mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-5mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100483-50mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
HY-100534-1mg
|
MedChemexpress LLC
|
IDE 2 [CAS 1136466-93-7]
|
|
|
|
HY-102001-10mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
HY-102001-25mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|